miR-17-5p Downregulation Contributes to Paclitaxel Resistance of Lung Cancer Cells through Altering Beclin1 Expression

Non- small- cell lung cancer (NSCLC) is one of the most leading causes of cancer-related deaths worldwide. Paclitaxel based combination therapies have long been used as a standard treatment in aggressive NSCLCs. But paclitaxel resistance has emerged as a major clinical problem in combating non-small...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatterjee, Abhisek, Chattopadhyay, Dhrubajyoti, Chakrabarti, Gopal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995800/
https://www.ncbi.nlm.nih.gov/pubmed/24755562
http://dx.doi.org/10.1371/journal.pone.0095716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995800/
https://www.ncbi.nlm.nih.gov/pubmed/24755562
http://dx.doi.org/10.1371/journal.pone.0095716

Ejemplares similares